Thiotepa
- Product NDC
- 70860-220
- 11-digit product format
- 708600220
- Labeler code
- 70860
- Product ID
- 70860-220_6a12eeea-ab98-42fe-8c5b-817d884dd44b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- thiotepa
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRACAVITARY; INTRAVENOUS; INTRAVESICAL
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA211831
- Marketing category
- ANDA
- Marketing start
- 2022-10-15
- Marketing end
- 0000-00-00
- Substance
- THIOTEPA
- Active strength
- 15 mg/1.5mL
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-220-02 | 70860022002 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-220-02) > 1.5 mL in 1 VIAL, SINGLE-DOSE | 2022-10-15 | 0000-00-00 | No | No | Current |